VasoRx
San Diego
About VasoRx
VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at Massachusetts Institute of Technology (M.I.T) and Yale for the delivery of RNAs for the treatment of diseases. With the world’s first approved RNAi therapeutic, the field of RNA medicines is rapidly expanding. VasoRx utilizes novel nanoparticles that are dramatically expanding the opportunities for developing RNA therapies for diseases of the cardiovascular system as well as oncology. system & oncology such as atherosclerosis and pulmonary hypertension.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.2M
- Last round: Grant (Nov 2020)
- Website: vasrx.com
- Phone: (619) 889-5199
Industries & Categories
Biotechnology, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vasorx-76502 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.